Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Aardvark Therapeutics, Inc.

NASDAQ: AARD · Life Sciences · 5 alerts · CIK 1774857

Share price
$1.26Close, Nov 16
Market cap
$27.6M
Shares outstanding
21.89MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Aardvark Therapeutics, Inc. filings on SEC EDGAR ↗

4:14 PM ET 8-K
Leadership Change

Aardvark Therapeutics Leadership Change

Aardvark Therapeutics appointed David (Zhongwei) Zhang, Ph.D., MBA, as a Class II director to its Board of Directors, effective October 7, 2026. Dr. Zhang brings over 25 years of experience in clinical strategy and biostatistics from roles at Abivax, Alumis, and MyoKardia. As a non-employee director, he will receive an annual cash retainer of $40,000 and an initial stock option grant valued at $500,000.

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.